Overall, ATS 2026 covered a variety of different areas in pulmonary and thoracic health, highlighting areas that require more ...
KB407’s positive set of results presented at ATS 2026 follows a set of similar positive results that were announced for the ...
The results provide validation of the DPP1 inhibition in bronchiectasis and reinforce the drug class’s position in this ...
Sex- and gender-informed thoracic care will emphasize developmental divergence in lung/cardiovascular health, tailored pulmonary hypertension management, and chromosomal contributions to ...
Clinical Trial Results in Pulmonary Medicine Advance Outcomes session, TETON-1 evaluated inhaled treprostinil in patients with idiopathic pulmonary fibrosis, a progressive disease associated with ...
LOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE)-- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that additional real-world clinical and economic data related ...
Genetic knockout of PABPC4 led to emphysema in mice. Photo by pocketlight//E+ via . At the American Thoracic Society (ATS) 2026 annual meeting on 18 May, during the B109 cellular, genetics, and ...
(MENAFN- GlobeNewsWire - Nasdaq) Includes real-world clinical data from Biodesix researchers and independent Healthcare Professionals LOUISVILLE, Colo., May 11, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results